Chimera Investment (NYSE:CIM) Stock Rating Lowered by Wall Street Zen

Chimera Investment (NYSE:CIM) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday.

Several other analysts also recently commented on CIM. UBS Group reduced their target price on Chimera Investment from $16.00 to $15.50 and set a “buy” rating for the company in a research note on Tuesday, November 18th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Chimera Investment in a research note on Monday, December 29th. Finally, Royal Bank Of Canada lowered Chimera Investment from an “outperform” rating to a “sector perform” rating and set a $13.00 price target on the stock. in a report on Tuesday, December 9th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Chimera Investment has a consensus rating of “Hold” and a consensus target price of $14.50.

Chimera Investment Stock Performance

NYSE:CIM opened at $13.55 on Friday. The company has a quick ratio of 8.22, a current ratio of 0.06 and a debt-to-equity ratio of 2.71. Chimera Investment has a twelve month low of $9.85 and a twelve month high of $14.88. The company has a fifty day moving average of $12.91 and a 200-day moving average of $13.11. The firm has a market capitalization of $1.13 billion, a P/E ratio of 7.74 and a beta of 1.84.

Chimera Investment (NYSE:CIM) last issued its earnings results on Wednesday, February 11th. The real estate investment trust reported $0.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.03. Chimera Investment had a net margin of 28.06% and a return on equity of 8.73%. The business had revenue of $72.01 million for the quarter, compared to analyst estimates of $80.77 million. As a group, sell-side analysts anticipate that Chimera Investment will post 1.57 EPS for the current year.

Institutional Trading of Chimera Investment

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CIM. SG Americas Securities LLC bought a new position in shares of Chimera Investment in the fourth quarter valued at approximately $7,431,000. Wolverine Asset Management LLC grew its holdings in Chimera Investment by 206.1% during the second quarter. Wolverine Asset Management LLC now owns 761,822 shares of the real estate investment trust’s stock worth $10,566,000 after buying an additional 512,909 shares in the last quarter. UBS Group AG raised its position in Chimera Investment by 130.7% in the 4th quarter. UBS Group AG now owns 763,691 shares of the real estate investment trust’s stock valued at $9,493,000 after buying an additional 432,727 shares during the last quarter. Ritholtz Wealth Management purchased a new stake in Chimera Investment in the 4th quarter valued at $4,977,000. Finally, Allianz Asset Management GmbH lifted its stake in Chimera Investment by 21.7% during the 3rd quarter. Allianz Asset Management GmbH now owns 1,671,318 shares of the real estate investment trust’s stock valued at $22,095,000 after acquiring an additional 297,709 shares in the last quarter. 48.44% of the stock is owned by institutional investors.

Chimera Investment Company Profile

Chimera Investment Corporation (NYSE: CIM) is a publicly traded real estate investment trust that specializes in investing in residential mortgage assets. The company’s portfolio primarily consists of agency and non-agency residential mortgage-backed securities, whole loan residential mortgages and other mortgage-related assets. As a REIT, Chimera Investment aims to generate attractive risk-adjusted returns through its focus on high-quality collateral and disciplined risk management.

The firm’s core business activities include identifying and acquiring portfolios of residential mortgage loans and securities from financial institutions and in the secondary market.